A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG

Publication | Open Access

DOI Full Paper Access

Citations

References

2014

Year

Carolien H. Smorenburg, S.M. de Groot, A. Elise van Leeuwen‐Stok, Marije E. Hamaker, A.N.M. Wymenga, H. de Graaf, Felix E. de Jongh, J.J. Braun, Maartje Los, E. Maartense,

Annals of Oncology

Breast OncologyOncologyElderly PatientsOmega StudyMedicineLiposomal DoxorubicinBreast CancerPharmacotherapyCancer TreatmentPharmacologyRadiation Oncology